US5605889A
(en)
*
|
1994-04-29 |
1997-02-25 |
Pfizer Inc. |
Method of administering azithromycin
|
WO1995030422A1
(en)
*
|
1994-05-06 |
1995-11-16 |
Pfizer Inc. |
Controlled-release dosage forms of azithromycin
|
JP3610418B2
(en)
*
|
1995-08-08 |
2005-01-12 |
カシオ計算機株式会社 |
Liquid crystal driving method and liquid crystal display device
|
US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
US20050064033A1
(en)
*
|
1997-04-11 |
2005-03-24 |
Notario Gerard F. |
Extended release formulations of erythromycin derivatives
|
US6551616B1
(en)
*
|
1997-04-11 |
2003-04-22 |
Abbott Laboratories |
Extended release formulations of erythromycin derivatives
|
GB9725219D0
(en)
*
|
1997-11-29 |
1998-01-28 |
Cleansharp Ltd |
Tablets
|
WO2000048475A1
(en)
*
|
1999-02-18 |
2000-08-24 |
Fujisawa Pharmaceutical Co., Ltd. |
Masking agent
|
US6239141B1
(en)
|
1999-06-04 |
2001-05-29 |
Pfizer Inc. |
Trovafloxacin oral suspensions
|
FR2795962B1
(en)
*
|
1999-07-08 |
2003-05-09 |
Prographarm Laboratoires |
PROCESS FOR THE MANUFACTURE OF MASK TASTE COATED GRANULES AND IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
US6541014B2
(en)
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
SI1390377T1
(en)
|
2001-05-22 |
2006-06-30 |
Pfizer Prod Inc |
New crystal form of azithromycin
|
ES2323264T3
(en)
*
|
2001-08-01 |
2009-07-10 |
Novartis Ag |
COMPOSITION FOR MASK OF FLAVOR.
|
EA200400214A1
(en)
*
|
2001-08-21 |
2004-06-24 |
Пфайзер Продактс Инк. |
AZITROMYCIN IN THE FORM OF SINGLE DOSE
|
US9358214B2
(en)
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
EP1541134A3
(en)
*
|
2001-10-18 |
2007-06-06 |
Teva Pharmaceutical Industries Limited |
Stabilized azithromycin compositions
|
NZ532063A
(en)
*
|
2001-12-21 |
2006-03-31 |
Pfizer Prod Inc |
Methods for wet granulating azithromycin
|
BR0215193A
(en)
*
|
2001-12-21 |
2004-11-16 |
Pfizer Prod Inc |
Directly compressible azithromycin formulations
|
MXPA04007427A
(en)
*
|
2002-02-01 |
2004-10-11 |
Pfizer Prod Inc |
Dry granulated formulations of azithromycin.
|
US7754701B2
(en)
*
|
2002-04-26 |
2010-07-13 |
Fancl Corporation |
Difructose anhydride-containing composition and use thereof
|
US20040170686A1
(en)
*
|
2003-01-31 |
2004-09-02 |
Fredrickson Jennifer K. |
Suspension vehicle for coated drug particles
|
US20040191326A1
(en)
*
|
2003-03-31 |
2004-09-30 |
Reo Joseph P. |
Taste-masking vehicle for coated oxazolidinone particles
|
EA200501552A1
(en)
*
|
2003-04-02 |
2006-04-28 |
Плива-Истраживанье И Развой Д.О.О. |
PHARMACEUTICAL COMPOSITIONS WITH LESS EXPRESSED BITTER TASTE
|
KR100503949B1
(en)
*
|
2003-04-28 |
2005-07-26 |
주식회사유한양행 |
A composition of fast dissolving tablets effectively masked bitter taste of ondansetron hydrochloride
|
EP1648472A2
(en)
*
|
2003-07-01 |
2006-04-26 |
Ranbaxy Laboratories, Ltd. |
Stable oral compositions of azithromycin monohydrate
|
US20050013835A1
(en)
*
|
2003-07-15 |
2005-01-20 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
JP2006528189A
(en)
|
2003-07-21 |
2006-12-14 |
アドバンシス ファーマスーティカル コーポレイション |
Antibiotic products, their use and formulation
|
JP2006528185A
(en)
|
2003-07-21 |
2006-12-14 |
アドバンシス ファーマスーティカル コーポレイション |
Antibiotic preparations, their use and preparation
|
JP2006528190A
(en)
|
2003-07-21 |
2006-12-14 |
アドバンシス ファーマスーティカル コーポレイション |
Antibiotic preparations, their use and preparation
|
WO2005016311A1
(en)
|
2003-08-11 |
2005-02-24 |
Advancis Pharmaceutical Corporation |
Robust pellet
|
CA2535398C
(en)
|
2003-08-12 |
2013-11-12 |
Advancis Pharmaceuticals Corporation |
Antibiotic product, use and formulation thereof
|
CA2535780A1
(en)
|
2003-08-29 |
2005-03-17 |
Advancis Pharmaceuticals Corporation |
Antibiotic product, use and formulation thereof
|
JP2007513869A
(en)
|
2003-09-15 |
2007-05-31 |
アドバンシス ファーマスーティカル コーポレイション |
Antibiotic preparations, their use and preparation
|
US20050084540A1
(en)
*
|
2003-10-17 |
2005-04-21 |
Indranil Nandi |
Taste masking antibiotic composition
|
US8168228B2
(en)
*
|
2003-10-17 |
2012-05-01 |
Sandoz Ag |
Antibiotic clarithromycin micropellet compositions
|
US20050101547A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Sadatrezaei Mohsen |
Stabilized azithromycin composition
|
ES2600577T3
(en)
*
|
2003-12-04 |
2017-02-09 |
Bend Research, Inc. |
Spray-solidification process using an extruder to prepare multiparticulate compositions of crystalline drugs
|
KR100844628B1
(en)
|
2003-12-04 |
2008-07-07 |
화이자 프로덕츠 인크. |
Method for making pharmaceutical multiparticulates
|
JP2007513139A
(en)
|
2003-12-04 |
2007-05-24 |
ファイザー・プロダクツ・インク |
Multiparticulate compositions with improved stability
|
WO2005053652A1
(en)
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
|
UA78793C2
(en)
*
|
2003-12-04 |
2007-04-25 |
Pfizer Prod Inc |
Oral dosage form of azitromycin with decreased side effects
|
KR20080064209A
(en)
*
|
2003-12-04 |
2008-07-08 |
화이자 프로덕츠 인코포레이티드 |
Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
|
WO2005053639A2
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Controlled release multiparticulates formed with dissolution enhancers
|
JP2007513146A
(en)
*
|
2003-12-04 |
2007-05-24 |
ファイザー・プロダクツ・インク |
Azithromycin multiparticulate dosage form by liquid process
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
JP2008505124A
(en)
|
2004-07-02 |
2008-02-21 |
アドバンシス ファーマスーティカル コーポレイション |
Pulse delivery tablets
|
US20060024335A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Roger Stier E |
Oral compositions which mask the bitter taste of a bitter-tasting agent
|
JP2006052169A
(en)
*
|
2004-08-12 |
2006-02-23 |
Wakoudou Kk |
Sol-like or gel-like administration assistant food
|
US8747895B2
(en)
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
EP2417969A1
(en)
|
2004-10-21 |
2012-02-15 |
Aptalis Pharmatech, Inc. |
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
|
DK2486942T3
(en)
|
2004-11-24 |
2019-01-28 |
Meda Pharmaceuticals Inc |
COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
|
US20070020330A1
(en)
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
US20060198885A1
(en)
*
|
2005-02-22 |
2006-09-07 |
Sun Pharmaceutical Industries Ltd. |
Oral pharmaceutical composition
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
AU2016202290B2
(en)
*
|
2005-06-17 |
2017-10-05 |
Wisconsin Alumni Research Foundation |
Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
|
US9101160B2
(en)
|
2005-11-23 |
2015-08-11 |
The Coca-Cola Company |
Condiments with high-potency sweetener
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
JP4963846B2
(en)
*
|
2006-03-03 |
2012-06-27 |
エルメッド エーザイ株式会社 |
Orally disintegrating tablet and method for producing the same
|
ES2355306T3
(en)
*
|
2006-03-16 |
2011-03-24 |
Novartis Ag |
SOLID DOSAGE FORM CONTAINING AN ACTIVE MASKED FLAVOR AGENT.
|
US8299052B2
(en)
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
US8017168B2
(en)
|
2006-11-02 |
2011-09-13 |
The Coca-Cola Company |
High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
|
EP2030644A1
(en)
*
|
2007-08-31 |
2009-03-04 |
PARI Pharma GmbH |
Aerosols for sinunasal drug delivery
|
CA2703475A1
(en)
|
2007-10-25 |
2009-04-30 |
Cempra Pharmaceuticals, Inc. |
Process for the preparation of macrolide antibacterial agents
|
TWI468167B
(en)
|
2007-11-16 |
2015-01-11 |
威佛(國際)股份有限公司 |
Pharmaceutical compositions
|
BRPI0906648A2
(en)
*
|
2008-01-31 |
2019-11-19 |
Mcneil Ppc Inc |
edible film strips for immediate release of active ingredients
|
EP2098219A1
(en)
*
|
2008-03-05 |
2009-09-09 |
PARI Pharma GmbH |
Macrolide compositions having improved taste and stability
|
US20100297232A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Monosol Rx, Llc |
Ondansetron film compositions
|
CN102958515A
(en)
|
2009-12-02 |
2013-03-06 |
阿普塔利斯制药有限公司 |
Fexofenadine microcapsules and compositions containing them
|
JP5259880B2
(en)
*
|
2010-09-01 |
2013-08-07 |
興和株式会社 |
Oral
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
US9945862B2
(en)
|
2011-06-03 |
2018-04-17 |
Eisai R&D Management Co., Ltd. |
Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
|
CA2864322C
(en)
*
|
2012-02-28 |
2016-08-09 |
Seoul Pharma. Co., Ltd. |
High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient
|
EP2830632A4
(en)
|
2012-03-27 |
2015-10-21 |
Cempra Pharmaceuticals Inc |
Parenteral formulations for administering macrolide antibiotics
|
RU2498805C1
(en)
*
|
2012-07-23 |
2013-11-20 |
Открытое акционерное общество "Биосинтез" |
Solid dosage form of azithromycin
|
CN103961368B
(en)
*
|
2013-12-05 |
2017-01-04 |
广西大学 |
Montmorillonite-loaded calcium hydroxide antacid
|
PL3524595T3
(en)
|
2014-08-28 |
2022-10-31 |
Eisai R&D Management Co., Ltd. |
High-purity quinoline derivative and method for manufacturing same
|
HUE064614T2
(en)
*
|
2015-02-25 |
2024-04-28 |
Eisai R&D Man Co Ltd |
Method for suppressing bitterness of quinoline derivative
|
KR20240064733A
(en)
|
2015-03-04 |
2024-05-13 |
머크 샤프 앤드 돔 코포레이션 |
Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
|
BR112017027227B1
(en)
|
2015-06-16 |
2023-12-12 |
Eisai R&D Management Co., Ltd |
ANTI-CANCER AGENT
|
EP3452023A1
(en)
|
2016-05-05 |
2019-03-13 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine compositions
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
BR112021009468A2
(en)
*
|
2018-11-16 |
2021-08-10 |
Ssp Co., Ltd. |
oral pharmaceutical formulation containing ibuprofen
|
WO2020237172A1
(en)
*
|
2019-05-23 |
2020-11-26 |
Xinova, LLC |
Compositions and methods for the treatment and mitigation of alcohol-induced skin flushing
|
MX2023007464A
(en)
*
|
2020-12-22 |
2023-08-30 |
Solugen Inc |
Bitter masking agent.
|